Clinical Ink has an employee rating of 3.4 out of 5 stars, based on 74 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Clinical Ink employee rating is in line with the average (within 1 standard deviation) for employers within the Information Technology industry (3.9 stars).
Unlimited Vacation
Ability to Work from home if needed
Great Co-Workers
Leadership that cares about your well being
Competitive pay
Growth Opportunities
Cons
Very deadline driven
Can be difficult to communicate with individuals in NC office
Even though we have rapidly accelerated our growth not only in employee size, but in product offerings within just a few years, we still hold that "start-up" "small company, family feel". That is what keeps me focused even during the harder days. We are all truly working towards the same mission of helping get drugs to the market faster to help those in need, and you can go to anyone in the company when you need assistance. I have never seen a company where the President (and co-founder) are just as hands-on and invested in the product and employees as everyone else.
Cons
Sometimes teams get so wrapped up in their own objectives they may forget the impact it has on others. We are still actively improving across team communication, and making changes to ensure we are not working in silos but remember our common company wide goals.
According to anonymously submitted Glassdoor reviews, Clinical Ink employees rate their compensation and benefits as 3.8 out of 5. Find out more about salaries and benefits at Clinical Ink. This rating has decreased by 2% over the last 12 months.
69% of Clinical Ink employees would recommend working there to a friend based on Glassdoor reviews. Employees also rated Clinical Ink 3.4 out of 5 for work life balance, 3.6 for culture and values and 3.3 for career opportunities.
Explore Glassdoor’s employee reviews to understand what current and former employees are saying about Clinical Ink layoffs and their outlook for job security at Clinical Ink in 2026.